Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV

被引：0
|
作者：
A. Rivero-Juarez
J. A. Mira
A. Camacho
K. Neukam
I. Perez-Camacho
A. Caruz
J. Macias
J. Torre-Cisneros
J. A. Pineda
A. Rivero
机构：
[1] Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC),Unidad de Enfermedades Infecciosas
[2] Hospital Universitario Reina Sofia,Unidad de Enfermedades Infecciosas
[3] Hospital Universitario Virgen de Valme,Departamento de Biología Molecular
[4] Hospital de Poniente,undefined
[5] Universidad de Jaen,undefined
来源：
Infection | 2013年 / 41卷
关键词：
HCV; HIV; End-of-treatment response; Viral relapse; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：21 / 26
页数：5
相关论文
共 50 条
  • [21] Rate of HCC occurrence and associated risk factors in a multicentric cohort of HIV/HCV co-infected patients treated with DAAs
    Toschi, A.
    Badia, L.
    Coladonato, S.
    Tazza, B.
    Ursitti, M. A.
    Salsi, E.
    Laccabue, D.
    Corsini, R.
    Massari, M.
    Degli Antoni, A.
    Sighinolfi, L.
    Mori, F.
    Cristini, F.
    Verucchi, G.
    Guardigni, V.
    HIV MEDICINE, 2019, 20 : 179 - 179
  • [22] MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients
    Moghoofei, Mohsen
    Najafipour, Sohrab
    Mostafaei, Shayan
    Tavakoli, Ahmad
    Bokharaei-Salim, Farah
    Ghorbani, Saied
    Javanmard, Davod
    Ghaffari, Hadi
    Monavari, Seyed Hamidreza
    CURRENT HIV RESEARCH, 2021, 19 (01) : 27 - 34
  • [23] Rapid and early virological response to chronic hepatitis C treatment with IFN α2b or PEG-IFN α2b plus ribavirin in HIV/HCV co-infected patients
    Payan, Christopher
    Pivert, Adeline
    Morand, Patrice
    Fafi-Kremer, Samira
    Carrat, Fabrice
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Lunel, Francoise
    GUT, 2007, 56 (08) : 1111 - 1116
  • [24] Factors associated with liver fibrosis in HIV/HCV co-infected patients
    Bani-Sadr, F
    Perronne, C
    Pol, S
    Rosenthal, E
    Carrat, F
    JOURNAL OF HEPATOLOGY, 2003, 38 : 126 - 126
  • [25] Prevalence of and risk factors for HCV RNA detection in HIV/HCV co-infected patients who are HCV antibody negative
    Boyle, B
    GASTROENTEROLOGY, 2002, 123 (01) : 49 - 49
  • [26] Sustained virologic response (SVR) following interferon (IFN) and ribavirin (RBV) therapy for hepatitis C (HCV) patients who are co-infected with HIV
    Dieterich, DT
    Suciu, L
    Goldman, DJ
    Weisz, KB
    Jonea, J
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 215 - 215
  • [27] Diabetes Mellitus in HIV/HCV Co-Infected Patients Treated with Ledipasvir and Sofosbuvir
    Bhatti, Zabeer
    Gill, Dalvir
    Virk, Jaswinder
    Sivalingam, Devamohan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1360 - S1360
  • [28] FACTORS PREDICTIVE OF SVR IN PATIENTS TREATED WITH PEG-IFN AND RIBAVIRIN FOR RECURRENT HCV AFTER LIVER TRANSPLANTATION
    Ghalib, Reem
    Levine, Cheryl
    Lammata, Praveena
    Cheah, Joann
    Mubarak, Abdullah
    Mantry, Parvez
    Weinstein, Jeffrey
    Anthony, Tiffany
    Dominguez, Edward
    Mejia, Alejandro
    Cheng, Stephen
    LIVER TRANSPLANTATION, 2009, 15 (07) : S242 - S242
  • [29] The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART
    Jevtovic, Dj.
    Ranin, J.
    Salemovic, D.
    Pesic, I.
    Dragovic, G.
    Zerjav, S.
    Djurkovic-Djakovic, O.
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (01) : 21 - 25
  • [30] Identification of mutations in the HVR1 and PKR-BD regions in HCV-infected patients resistant to PEG-IFNα/RBV therapy
    Holysz, M.
    Bialas, K.
    Migdalski, P.
    Kmieciak, D.
    Trzeciak, W. H.
    JOURNAL OF APPLIED GENETICS, 2015, 56 (03) : 403 - 409
12345